PHARMACEUTICAL COMPOSITION COMPRISING A DUAL REUPTAKE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF

摘要

The present invention relates to a stable pharmaceutical formulation for oral administration comprising a therapeutically effective amount of a serotonin-norepmephrine reuptake inhibitor or a pharmaceutically acceptable salt thereof, in particular Duloxetine that inhibits degradation and or hydrolysis of the active ingredient. It also relates to a process for the preparation thereof.